Amphastar Pharmaceuticals (AMPH) Asset Utilization Ratio (2014 - 2026)

Amphastar Pharmaceuticals' Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.44 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 3.6% year-over-year to 0.44 in Q1 2026; TTM through Mar 2026 was 0.44, a 3.6% decrease from a year earlier, with the FY2025 full-year figure at 0.45, down 5.22% from the prior year.
• Asset Utilization Ratio advanced to 0.44 in Q1 2026 per AMPH's latest filing, from 0.44 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.68 in Q1 2023 and bottomed at 0.41 in Q3 2023.
• The 5-year median for Asset Utilization Ratio is 0.47 (2024), against an average of 0.51.
• Across the five-year window, Asset Utilization Ratio sank 38.46% in 2023 and gained 15.82% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.68 in 2022, then tumbled by 37.97% to 0.42 in 2023, then climbed by 11.22% to 0.47 in 2024, then slipped by 6.81% to 0.44 in 2025, then advanced by 0.64% to 0.44 in 2026.
• Per Business Quant, the three latest AMPH Asset Utilization Ratio figures stand at 0.44 (Q1 2026), 0.44 (Q4 2025), and 0.44 (Q3 2025).